Anthropic IPO Reportedly Oversubscribed Multiple Times as Valuation Could Reach $1.9 Trillion
Key Takeaways
- •Demand for Anthropic's IPO has reportedly reached several times the available share supply, potentially driving the final price above the indicated $70 to $78 per-share range.
- •Approximately 20% of the offering is reportedly set aside for retail investors, an unusually large share for a deal of this scale, although allocations may be scaled back given the depth of demand.
- •Pricing is expected on November 18, with trading on Nasdaq under the ticker $ANT scheduled to start November 19.
- •Contracts on Hyperliquid imply a fully diluted valuation of roughly $1.9 trillion, about 37% above the valuation suggested by the upper end of the IPO price range.
- •Anthropic is targeting as much as $90.4 billion in combined IPO and private placement funding, a total that could exceed the record previously set by SpaceX.

Anthropic's planned initial public offering (IPO) is reportedly attracting demand several times greater than the number of shares available, a level of interest that could push the final offering price above the expected range of $70 to $78 per share. The artificial intelligence company is expected to price the offering on November 18, with shares scheduled to begin trading on Nasdaq on November 19 under the ticker symbol $ANT.
According to information shared by Coin Bureau on X, approximately 20% of the IPO has reportedly been reserved for retail investors, an unusually large allocation for an offering of this scale. Demand could still significantly exceed the shares available, however, meaning individual investors may receive substantially fewer shares than they request.
The reported oversubscription adds pressure to the final pricing decision. Under standard IPO mechanics, demand of this magnitude gives the underwriters two levers: lifting the price above the marketed range or scaling back the shares assigned to each order. If demand remains strong, Anthropic could set the IPO price above the initial $70–$78 range, although the final figure has not yet been established.
Retail Investors Face Potentially Smaller Allocations
The reported 20% retail allocation represents a notable portion of the planned offering. It provides individual investors with access to shares, but the depth of demand could limit how much each participant ultimately receives. Even investors who submit orders for larger quantities may be allocated only a fraction of the shares they request if the IPO remains heavily oversubscribed.
Offerings of this size are typically allocated predominantly to institutional orders, which is part of why the reported retail reservation has drawn attention in its own right. The gap between demand and available supply could therefore become a key factor in determining the final allocation process.
Hyperliquid Contracts Point to $1.9 Trillion Valuation
Valuation expectations are also drawing attention in the derivatives markets. Contracts traded on Hyperliquid imply a fully diluted valuation of approximately $1.9 trillion for Anthropic, according to figures cited by Coin Bureau. A fully diluted measure counts every share that would exist if instruments such as options or warrants were converted, a broader basis than the shares sold in the offering alone.
That implied valuation is 37% above the level represented by the upper end of the reported IPO price range, suggesting that expectations embedded in the contracts sit substantially above the valuation implied by the initial $70–$78 pricing range.
The Hyperliquid figure, however, reflects an implied valuation derived from contract pricing rather than a confirmed IPO valuation. The final offering price will determine the valuation ultimately established through the public listing.
Anthropic Targets Up to $90.4 Billion in Combined Funding
Anthropic is aiming to raise as much as $90.4 billion through the IPO and a private placement combined. If achieved, the fundraising total could surpass the record previously set by SpaceX.
Taken together, the combined fundraising target, the reported oversubscription, and the $1.9 trillion fully diluted valuation implied by Hyperliquid contracts have placed the upcoming listing under close attention. With pricing expected on November 18 and Nasdaq trading set to begin on November 19 under the $ANT ticker, the final IPO price remains the central figure investors are waiting to see. That decision will show whether the offering settles inside the $70–$78 range or above it, and the first trading session the following day will establish the initial openly traded reference point for the stock.
Source: Hokanews